Technology Articles
Featured Articles
Read our latest stories on the people and scientific innovations making a difference in patients’ lives.
Born in Brooklyn: Celebrating Nearly 180 Years of American Innovation
As the United States celebrates its 250th anniversary this year, Pfizer is reflecting on its own place in America’s long history of innovation and looking ahead to the next wave of discoveries we aim to achieve.Founded in Brooklyn, New York, in 1849, Pfizer began with two entrepreneurs and a commitment to applying science to improve people’s lives. Nearly 180 years later, Pfizer colleagues continue to build on that legacy, advancing science with the potential to make a difference for people...
Pfizer Learns to Speak AI with Fluency Program
Technology moves fast, and there’s no better example than the rapid growth of artificial intelligence (AI).Here at Pfizer, we have long been focused on making breakthroughs that change patients’ lives. As new technology like AI emerges that can help us pursue our goals, we are committed to learning how best to apply AI to help make those breakthroughs even more quickly and efficiently. CEO Albert Bourla is leading the way with his vision for the future of Pfizer. His goal is to leverage AI...
How AI Is Helping Match Patients to Clinical Trials Faster
Long before reaching pharmacy shelves, every new medicine must complete one or more clinical trials. But before researchers can determine whether a potential new treatment is effective, they have to find enough eligible volunteers willing and able to participate in a trial. This process represents one of the biggest challenges in drug development.Patient enrollment is the cornerstone of every clinical trial, but it’s usually the longest phase of the process. Recruiting enough eligible...
The Hidden Infrastructure Behind Every Pfizer Medicine
Getting a medication can seem as simple as a trip to the pharmacy. In reality, that moment is the last step in a complex, rigorous, and largely invisible process.Behind every dose, an extraordinarily complex manufacturing operation helps produce medicines consistently, regardless of where they’re made or where they’ll be used. From qualifying raw material suppliers to monitoring production in real time, pharmaceutical manufacturing depends on thousands of coordinated decisions, rigorous...
How Pfizer Thinks About AI
At Pfizer, our ambition is to be the most AI-forward company in our industry, and we are making great progress every day. I spend more time thinking about it than almost anything else because I believe this is an unprecedented opportunity. AI will fundamentally improve how we discover medicines, how we develop and manufacture them and how quickly we reach patients. Very few technologies can change every corner of a business in this way.AI adoption is one thing — nearly every company has done it...
Then vs. Now: Flow Chemistry
The way medicines are made has changed significantly over time. Many of today’s drug molecules are larger and more complex than those developed decades ago and the methods for synthesis have evolved accordingly. As chemists design increasingly sophisticated molecules, they also need more precise and flexible ways to carry out the reactions that produce them.For much of history, chemists have carried out reactions in static vessels such as flasks in the lab or large reactors in manufacturing...
Then vs. Now: Molecular Design
Developing a new medicine starts at the most fundamental level: understanding how disease works. That often means looking beyond what we can observe directly and studying how molecules interact with biological targets.Much of what drives disease and how we treat it happens at a scale too small to see. In drug discovery, scientists study how molecules find, bind to, and influence their targets. The strength and specificity of these interactions play a critical role in determining how effective a...
Building an AI-Fluent Organization: How Pfizer is helping colleagues understand, embrace, and apply AI
Pfizer has been utilizing artificial intelligence (AI) across our business for some time, but recent advancements in technology combined with advancements in biology are converging to create a scientific renaissance set to transform health as we know it. That reality is already upon us.According to Pfizer CEO Albert Bourla, the biggest barrier to unlock this potential is fear of the unknown. "It is not a question of technology," Bourla said in a recent conversation with Nikolai Tangen of the...
How Biomarker Testing Helped a Lung Cancer Patient Get the Treatment She Needed
Earlier this month, Science Will Win, Pfizer’s award-winning podcast, wrapped up another successful season. Launched in February, season 6 included five episodes, each one focused on a different aspect of the fight against cancer, wrapping with last week’s season finale about AI’s impact on cancer care.All season long, each podcast episode has been accompanied by a full-length video conversation between host Dr. Raven Baxter – a molecular biologist and science educator – and one of her guests...
CEO Albert Bourla Reflects on Pfizer’s Year of Bold Moves and Relentless Innovation in 2025 Annual Review
2025 was a typically busy year for Pfizer, one of strong performance, disciplined execution and bold moves that position us for future growth and lasting impact for patients around the world as we continue to pursue our mission of making breakthroughs that change people’s lives.The entire organization remained focused on addressing the world’s most pressing health challenges, and 2025 was a year of significant progress toward that goal. We’ve detailed some of the highlights in our latest Annual...
The 6th Season of 'Science Will Win' Takes on Cancer
On February 4th, Pfizer observed World Cancer Day, a global effort to raise awareness of cancer and to encourage its prevention, detection, and treatment. We are on a mission to outdo cancer and make 8 breakthroughs in the fight against the disease by 2030.It all starts with education, which is why we’re excited to announce that the new season of our award-winning flagship podcast, Science Will Win, which launched today, is tackling cancer head-on with the help of expert doctors and scientists.N...
Pfizer Enters into Agreement with Walgreens to Help Eligible U.S. Adults Navigate Their Healthcare Journey
Winter is a busy time of year. The one thing you don’t want to let fall by the wayside is your health, especially with colder weather potentially bringing an increase in COVID-19, flu, and other respiratory viruses.For some adults, keeping up with their health, including understanding which vaccinations they may be eligible to receive, may feel like a daunting task. The agreement between Pfizer and Walgreens is intended to help make the process more connected and personal.We recently launched a...
Media Resources & Contact Information
Anyone may view our press releases, press statements, and press kits. However, to ensure that customers, investors, and others receive the appropriate attention, Pfizer Media Contacts may only respond to calls and emails from professional journalists.